Fuzhi Song

Chief Executive Officer chez GENEX PHARMACEUTICAL, INC.

70 ans

Health Technology

Profil

Fuzhi Song is currently the Chairman, President & Chief Executive Officer at Genex Pharmaceutical, Inc. since 2004 and also the Chairman at Tianjin Zhongjin Biology Development Co. Ltd.
since 2003.
Previously, he was the Chief Executive Officer at Tianjin Zhongjin Pharmageutical Co. Ltd.
from 1998 to 1999 and Chairman at Tianjin Jinshi Group.

Postes actifs de Fuzhi Song

Sociétés	Poste	Début
GENEX PHARMACEUTICAL, INC.	Chief Executive Officer	-
Tianjin Zhongjin Biology Development Co. Ltd. Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million.	Chairman	24/02/2010

Tous les postes actifs de Fuzhi Song

Anciens postes connus de Fuzhi Song

Sociétés	Poste	Fin
Tianjin Zhongjin Pharmageutical Co. Ltd.	President	01/11/1999
Tianjin Jinshi Group	Chairman	01/01/1999

Voir l'expérience en détail de Fuzhi Song

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Fuzhi Song

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées	1
GENEX PHARMACEUTICAL, INC.	Health Technology

Entreprise privées	3
Tianjin Zhongjin Biology Development Co. Ltd. Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million.	Health Technology
Tianjin Zhongjin Pharmageutical Co. Ltd.
Tianjin Jinshi Group

Voir les connexions sociétés

Bourse
Insiders
Fuzhi Song